Golimumab pharmacokinetics in ulcerative colitis: a literature review

Golimumab (GLM) is the latest anti-tumor necrosis factor (TNF) that gained its marketing license. Thanks to the PURSUIT induction and maintenance trials, it was approved for the treatment of ulcerative colitis (UC) in 2013. The other anti-TNF drugs available are infliximab and adalimumab. These two...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Therap Adv Gastroenterol
Main Authors: Harzallah, Ines, Rigaill, Josselin, Williet, Nicolas, Paul, Stephane, Roblin, Xavier
Format: Artigo
Sprog:Inglês
Udgivet: SAGE Publications 2016
Fag:
Reviews
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5330616/
https://ncbi.nlm.nih.gov/pubmed/28286562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X16676194
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker